PARBJEET KAUR: Open Payments
NPI 1336719186 · MOUNTAIN HOUSE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$465 in 21 payments from 12 companies in 2025. Trend: 2023 $182 · 2024 $496 · 2025 $465
Food & beverage: $465
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $108 |
| SCILEX PHARMACEUTICALS INC. | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Kowa Pharmaceuticals America, Inc. | 2 | $50 |
| Amgen Inc. | 2 | $44 |
| Astellas Pharma US Inc | 2 | $32 |
| Corcept Therapeutics | 2 | $32 |
| Novo Nordisk Inc | 1 | $24 |
| ANI Pharmaceuticals, Inc. | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
Products named: ACCOLADE SR, ZTLido, General - Pain Management, FARXIGA, ZORYVE, OTEZLA, Veozah, Korlym.
Industry payments across CA — which companies pay providers there.
